MDDVF (Medical Developments International) Long-Term Debt: $1.00 Mil (As of Dec. 2025)


MDDVF Medical Developments International Ltd MDDVF
51 GF Score
Price $0.37
GF Value $0.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Long-Term Debt?

Medical Developments International MDDVF 51 Long-Term Debt is $1.00 Mil as of Dec. 2025. GuruFocus rates MDDVF with a GF Score™ of 51/100 and a GF Value™ of $0.39 (Fairly Valued). The stock has 2 warning signs investors should review.

Medical Developments International's Long-Term Debt for the quarter that ended in Dec. 2025 was $1.00 Mil.

Medical Developments International's quarterly Long-Term Debt declined from Dec. 2024 ($1.12 Mil) to Jun. 2025 ($0.00 Mil) but then increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($1.00 Mil).


Medical Developments International  (OTCPK:MDDVF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Medical Developments International Long-Term Debt Related Terms


Medical Developments International Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medical Developments International's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International Long-Term Debt Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 0.00 1.12 0.00 1.00
MDDVF
51GF Score
Medical Developments International Ltd MDDVF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $1.00 Mil mean?
Medical Developments International (MDDVF) has a Long-Term Debt of $1.00 Mil as of Dec. 2025.
Is Medical Developments International's Long-Term Debt too high?
Medical Developments International's current Long-Term Debt is $1.00 Mil. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Long-Term Debt compare to ZTS and UTHR?
Medical Developments International's Long-Term Debt of $1.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medical Developments International's current Long-Term Debt is $1.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (MDDVF) is currently considered Fairly Valued. The stock's GF Value™ is $0.39, compared to a current price of $0.37 — trading 5.1% below its estimated fair value. The current Long-Term Debt is $1.00 Mil. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medical Developments International (MDDVF), the current Long-Term Debt is $1.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (MDDVF) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of $0.37 is trading 5.1% below its estimated GF Value™ of $0.39. GuruFocus considers Medical Developments International to be Fairly Valued.

Key valuation signals for MDDVF:

  • Long-Term Debt: $1.00 Mil
  • GF Value™: $0.39 vs. price of $0.37 (5.1% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the MDDVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Developments International Business Description

Other Exchanges M5D:GermanyMVP:Australia
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score

Get the complete analysis for MDDVF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.39
GF Value